No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
55 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Emory University · Other
Who this trial is looking for
This trial is looking for adults over 55 who have had a stroke with an unknown cause. Participants will wear a smartwatch for 30 days to help monitor their heart rhythm.
Are You a Good Fit for This Trial?
You may be able to join if
I am 55 years old or older.
I have had an ischemic stroke with an unknown cause.
I am receiving follow-up treatment at the Emory Stroke Clinic.
I have been prescribed extended cardiac monitoring.
I can give informed consent.
I understand English and how to use the study wrist device.
You may not be able to join if
I am younger than 55 years old.
I do not need extended cardiac monitoring.
I cannot understand English or follow instructions for the wrist device.
I have structural valve disease.
I have endocarditis.
I have aortic arch atheroma larger than 3 mm.
I have a condition that makes me prone to blood clots.
I am on lifelong anticoagulation medication.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Atrial Fibrillation (AF) is an abnormal heart rhythm. Because AF is often asymptomatic, it often remains undiagnosed in the early stages. Anticoagulant therapy greatly reduces the risks of stroke in patients diagnosed with AF. However, diagnosis of AF requires long-term ambulatory monitoring procedures that are burdensome and/or expensive.
Smart devices (such as Apple or Fitbit) use light sensors…
Atrial Fibrillation (AF) is an abnormal heart rhythm. Because AF is often asymptomatic, it often remains undiagnosed in the early stages. Anticoagulant therapy greatly reduces the risks of stroke in patients diagnosed with AF. However, diagnosis of AF requires long-term ambulatory monitoring procedures that are burdensome and/or expensive.
Smart devices (such as Apple or Fitbit) use light sensors (called "photoplethysmography" or PPG) and motion sensors (called "accelerometers") to continuously record biometric data, including heart rhythm. Smart devices are already widely adopted.
This study seeks to validate an investigational machine-learning software (also called "algorithms") for the long-term monitoring and detection of abnormal cardiac rhythms using biometric data collected from consumer smart devices.
The research team aims to enroll 500 subjects who are being followed after a stroke event of uncertain cause at the Emory Stroke Center. Subjects will undergo standard long-term cardiac monitoring (ECG), using FDA-approved wearable devices fitted with skin electrodes or implantable continuous recorders, and backed by FDA-approved software for abnormal rhythm detection.
Patients will wear a study-provided consumer wrist device at home, for the 30 days of ECG monitoring, 23 hours a day. At the end of the 30 days, the device data will be uploaded to a secure cloud server and will be analyzed offline using proprietary software (called "algorithms") and artificial intelligence strategies. Detection of AF events using the investigational algorithms will be compared to the results from the standard monitoring to assess their reliability. Attention will be paid to recorded motion artifacts that can affect the quality and reliability of recorded signals.
The ultimate aim is to establish that smart devices can potentially be used for monitoring purposes when used with specialized algorithms. Smart devices could offer an affordable alternative to standard-of-care cardiac monitoring.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Adults 55 years of age or older.
* Post-discharge with diagnostic of index ischemic stroke with uncertain cause.
* Subject must be treated at the Emory Stroke Clinic for follow-up treatment.
* Subject must be prescribed a clinical extended cardiac monitoring.
* Subject or thei…
Inclusion Criteria:
* Adults 55 years of age or older.
* Post-discharge with diagnostic of index ischemic stroke with uncertain cause.
* Subject must be treated at the Emory Stroke Clinic for follow-up treatment.
* Subject must be prescribed a clinical extended cardiac monitoring.
* Subject or their Legal Authorized Representative (LAR) must be willing and able to provide informed consent.
* Subject, family proxy, or caregiver must understand English and the instructions to manage and recharge the study wrist device.
Exclusion Criteria:
* Subject is younger than 55 years of age at the time of consent.
* No indication for clinical extended cardiac monitoring.
* Subject, family proxy, or caregiver unable to understand English and unable to follow the instructions on how to manage and recharge the study wrist device.
* Subject has a diagnosis of structural valve disease, endocarditis, aortic arch atheroma \>3 mm, hypercoagulability, on lifelong anticoagulation, or has an active neoplastic disease
* Subject or LAR is not willing or able to provide informed consent.
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.